The revenue stands at ₹43.79 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.99 per cent from ₹44.23 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Operating Profit stands at ₹20.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.39 per cent from ₹19.36 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
PBDT stands at ₹19.14 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.13 per cent from ₹18.38 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Profit Before Tax stands at ₹15.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.79 per cent from ₹14.34 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Net Profit stands at ₹11.07 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.65 per cent from ₹10.89 crore. This represents a 0.00 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Guj. Themis Bio. | -0.54% | 2.68% | -3.88% | 1.19% | 14.61% | 2.26% |
| RPG LifeScience. | 0.56% | -2.13% | -5.91% | 14.60% | 32.18% | 16.12% |
| Gufic BioScience | 1.21% | 10.67% | 8.89% | 46.24% | 38.74% | 23.03% |
| Morepen Labs. | 0.04% | 3.00% | 27.34% | 84.67% | 103.18% | 69.80% |
| Novartis India | -0.67% | -2.35% | -4.45% | 26.64% | 91.91% | 69.65% |
| Aarti Drugs | 0.67% | 3.36% | 7.82% | 14.27% | 13.51% | -12.97% |
| Unichem Labs. | 1.27% | 3.85% | -13.69% | 41.48% | 34.00% | 6.38% |
Chairman & Non Executive Dir. : Dinesh S Patel
Managing Director : Sachin D Patel
Independent Non Exe. Director : Kirandeep Madan
Independent Non Exe. Director : Hitesh Dharmasinh Gajaria
Independent Non Exe. Director : K G Ananthakrishnan
Independent Director : NIHAR AJAY PARIKH
Additional Director : Rajneesh Anand